Navigation Links
Dr. Fischer Said It Will Notify Pediatricians That Its Baby Eyelid Wipes Are Available At U.S. Pharmacies Contrary To What A Competitor Is Saying In Advertising About Its Wipes For Babies Being The 'First And Only' In The U.S. Market
Date:8/13/2012

NEW YORK, Aug. 13, 2012 /PRNewswire/ -- Dr. Fischer, the global pharmaceutical company based in Israel, said today it will send a letter to Pediatricians, Ophthalmologists and Pharmacists notifying them that its baby eyelid wipes have been available for some time at U.S. pharmacies contrary to what an eye-care competitor is saying in advertising about its baby eyelid & eyelash cleanser being the "first and only" such wipes in the U.S. market.

Not only does it plan to correct the record, but Dr. Fischer will take the opportunity also to point out that no one can miss its brand and world famous logo in pharmacies and that its eye-care wipes for babies individually are not only a superior product according to many pediatricians, but even much larger in size than the competitor's brand. 

"Dr. Fischer's baby eyelid wipes have been available at U.S. pharmacies since December 2008," said Tom Madden, CEO of  Dr. Fischer's public relations firm in the U.S., TransMedia Group (www.transmediagroup.com).   

"The Dr. Fischer eye-care for babies product started out on a small scale at private pharmacies and since June of this year distribution and sales have expanded significantly as more and more pediatricians and pharmacists started recommending Dr. Fischer Baby Eye-Care Wipes as well as other Dr. Fischer eye-care products," Madden said.

"All that Dr. Fischer is seeking to do is to make it known that there is not only one, but two eyelid wipes for children on the market and that Dr. Fischer's product has been available for some time," Madden said. 

"There's no reason why competitors can't compete amicably as long as that what they say about the market is accurate."

About Fischer Pharmaceuticals

Fischer Pharmaceuticals is a world leader in the development and manufacture of advanced health care preparations in the fields of dermatology, opthalmology and nutraceuticals.

The company's innovative R&D continually sets trends and norms in the industry, utilizing its' medical know-how with advanced pharmaceutical technology to offer consumers the best of both worlds; science and nature.

Media contact: Donna Balancia, 561-750-9800 x223 or donna@transmediagroup.com


'/>"/>
SOURCE Fischer Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Jennerex Appoints Dr. Laurent Fischer as President and Chief Executive Officer
2. New Reproductive Support Dietary Supplement, Pregnitude™, Now Available For Women Having Difficulty Conceiving
3. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
4. Anatabloc® Retail Expansion with GNC Complete: Product Now Available at all GNC Corporate Stores and GNC.com
5. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
6. FUJIFILM Synapse® Mobility 3.0 Now Available In The U.S.
7. Telescope Implant for End Stage Macular Degeneration Now Available Across the Nation
8. Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
10. Cytomedix, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
11. DATATRAK International, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... NESS ZIONA SCIENCE PARK , ... Israeli biotechnology company Kadimastem (TASE: KDST) announced today the signing of ... strategic collaboration between the companies. The synergy between the companies will ... Kadimastem-Corestem collaboration as a worldwide leader in innovative treatment for severe ... ...
(Date:12/7/2016)... -- Based on its recent analysis of the ... recognizes Nemaura Pharma Limited with the 2016 ... Technology Leadership. Nemaura Pharma,s transdermal drug delivery ... delivery technologies, especially in delivering biologics. Its ... Memspatch and Micropatch respectively, facilitate minimally painful ...
(Date:12/7/2016)... 2016 According to the latest ... Market Study on Multiplex Detection Immunoassay: North America to ... global multiplex detection immunoassay market is expected to witness a CAGR ... ...      (Logo: http://photos.prnewswire.com/prnh/20161114/438683LOGO) ...
Breaking Medicine Technology:
(Date:12/7/2016)... (Dec. 3, 2016) , ... (PRWEB) December 07, ... ... only patient advocacy nonprofit for individuals impacted by cerebral cavernous angiomas, was awarded ... New Mexico with a patient engagement program. New Mexico has more people with ...
(Date:12/7/2016)... ... 2016 , ... Dr. Greg Leyer, the Chief Scientific Officer ... DC workshop on November 2nd. The conference was an opportunity for both probiotic ... regulations. , Dr. Leyer spoke about two main topics at the IPA ...
(Date:12/7/2016)... Warwick, New York (PRWEB) , ... December 07, 2016 , ... ... computer professor at Yale had described him as 'a genius.'" Thus begins "Margaret in ... R. L. Rhyse and published by Wyston Books, Inc. These novels narrate ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... collaborate in developing a vaccine against the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). ... available in South Korea for emergency deployment in the event of a future ...
(Date:12/6/2016)... ... , ... Individuals who seek to reduce the effects of aging can take ... exposure to the sun, according to a November 30 article published on ... that, while preventive measures to help keep ourselves looking our best always make sense, ...
Breaking Medicine News(10 mins):